Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POPCICLE: Ciclesonide in children with mild asthma
NCT00163293Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2005
- Primary completion
- Jun 2009
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial of ciclesonide in asthma (3 arms), sponsored by AstraZeneca. Primary endpoints: Time to First Asthma Exacerbation at 12 months and Exacerbations (Post-hoc Analysis of Annual Rates) at 12 months. Started Jan 2005; status: completed.
02
Drugs
ciclesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00163293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00163293.